Sirtuins: Novel targets for metabolic disease in drug development
- 23 June 2008
- journal article
- review article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 373 (3) , 341-344
- https://doi.org/10.1016/j.bbrc.2008.06.048
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetesNature, 2007
- Dynamic FoxO transcription factorsJournal of Cell Science, 2007
- Fasting-dependent glucose and lipid metabolic response through hepatic sirtuin 1Proceedings of the National Academy of Sciences, 2007
- Sirtuins in mammals: insights into their biological functionBiochemical Journal, 2007
- Resveratrol improves health and survival of mice on a high-calorie dietNature, 2006
- Sirt1: a metabolic master switch that modulates lifespanNature Medicine, 2006
- Sirtuin activators mimic caloric restriction and delay ageing in metazoansNature, 2004
- Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-γNature, 2004
- Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespanNature, 2003
- Global and societal implications of the diabetes epidemicNature, 2001